Data / Drug companies / Medtech Products Inc.
Medtech Products Inc.: 56 products in the FDA NDC directory, labeler code 63029
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Medtech Products Inc. (labeler code 63029) lists 56 products in the FDA National Drug Code Directory, covering 24 finished drugs by generic name. By type: 56 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 1, 2026.
The request: Watch Medtech Products Inc. (FDA labeler code 63029): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63029
- Products in commercial distribution
- 56
- Packages
- 110
- Finished drugs by generic name
- 24
- Prescription products
- 0
- Over the counter products
- 56
- Flagged as original packager
- 55 of 55 products that carry the flag
- Started marketing in the last 12 months
- 7
- Products with a marketing end date set
- 2
- Earliest marketing start
- January 4, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 52 | 92.9% |
| New drug applications (NDA) | 2 | 3.6% |
| Other unapproved drugs | 2 | 3.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 56 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 9 | 330 |
| Meclizine hydrochloride | 7 | 41 |
| Aspirin and caffeine | 6 | 10 |
| Dimenhydrinate | 5 | 21 |
| Acetaminophen, aspirin, and caffeine | 4 | 13 |
| Aspirin | 2 | 134 |
| Carbamide peroxide | 2 | 37 |
| Cimetidine | 2 | 19 |
| Acetaminophen | 2 | 214 |
| Isopropyl alcohol | 2 | 177 |
| Diphenhydramine hcl | 2 | 99 |
| Polyvinyl alcohol and povidone | 1 | 2 |
| Diphenhydramine hydrochloride | 1 | 127 |
| Acetaminophen and diphenhydramine | 1 | 2 |
| Simthicone | 1 | 1 |
| Aspirin, acetaminophen, caffeine | 1 | 3 |
| Benzocaine | 1 | 110 |
| Acetaminophen and diphenhydramine hcl | 1 | 6 |
| Acetaminophen and aspirin and caffeine | 1 | 2 |
| Calcium polycarbophil | 1 | 33 |
| Acetaminophen and diphenhydramine citrate | 1 | 2 |
| Phenazopyridine hydrochloride | 1 | 53 |
| Acetaminophen and asprin | 1 | 1 |
| Acetaminophen, simethicone, zinc oxide | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 15 | 26.8% |
| Liquid | 10 | 17.9% |
| Tablet | 9 | 16.1% |
| Tablet, chewable | 8 | 14.3% |
| Plaster | 6 | 10.7% |
| Tablet, coated | 3 | 5.4% |
| Solution/ drops | 1 | 1.8% |
| Tablet, film coated | 1 | 1.8% |
| Capsule, coated | 1 | 1.8% |
| Gel | 1 | 1.8% |
| Kit | 1 | 1.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dramamine chewable orange | 63029-915 | Tablet, chewable | Over the counter monograph drugs | August 1, 2026 |
| Fibercon | 63029-170 | Tablet | Over the counter monograph drugs | July 31, 2026 |
| Dramamine | 63029-914 | Tablet, chewable | Over the counter monograph drugs | February 2, 2026 |
| Dramamine | 63029-913 | Tablet, chewable | Over the counter monograph drugs | February 2, 2026 |
| Dramamine | 63029-912 | Powder | Over the counter monograph drugs | February 2, 2026 |
| Goodys max | 63029-668 | Powder | Over the counter monograph drugs | February 2, 2026 |
| Compound W One Step Medicated Corn Remover | 63029-621 | Plaster | Over the counter monograph drugs | December 1, 2025 |
| Compound W Corn Remover | 63029-599 | Plaster | Over the counter monograph drugs | May 9, 2025 |
| Dramamine for Kids | 63029-908 | Tablet, chewable | Over the counter monograph drugs | February 17, 2025 |
| GOODYS Mental Alert | 63029-667 | Powder | Over the counter monograph drugs | February 17, 2025 |
| Debrox Kids | 63029-325 | Liquid | Over the counter monograph drugs | June 1, 2024 |
| Tagamet | 63029-223 | Tablet | New drug applications (NDA) | February 1, 2023 |
| Stye | 63029-324 | Solution/ drops | Over the counter monograph drugs | December 1, 2021 |
| Bc max | 63029-203 | Powder | Over the counter monograph drugs | March 15, 2020 |
| GOODYS Hangover | 63029-665 | Powder | Over the counter monograph drugs | November 15, 2019 |
| Debrox Swimmers Ear | 63029-323 | Liquid | Over the counter monograph drugs | April 1, 2019 |
| Dramamine | 63029-906 | Tablet, chewable | Over the counter monograph drugs | February 15, 2019 |
| Uristat Ultra | 63029-105 | Tablet | Other unapproved drugs | February 15, 2018 |
| Compound W for Kids One Step Strips | 63029-598 | Plaster | Over the counter monograph drugs | January 18, 2018 |
| Dramamine - n | 63029-905 | Tablet | Over the counter monograph drugs | January 15, 2018 |
| Little remedies new baby essentials | 63029-615 | Kit | Other unapproved drugs | February 15, 2017 |
| GOODYS Extra Strength Headache Mixed Fruit Blast | 63029-664 | Powder | Over the counter monograph drugs | August 1, 2015 |
| Compound W Maximum Strength One Step Invisible | 63029-596 | Plaster | Over the counter monograph drugs | March 15, 2014 |
| Compound W | 63029-595 | Gel | Over the counter monograph drugs | March 15, 2014 |
| Compound W One Step Pads | 63029-594 | Plaster | Over the counter monograph drugs | March 15, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.